Back

Randomized comparison of left atrial appendage closure and oral anticoagulation after catheter ablation for atrial fibrillation: subanalysis of AF type

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Clinical aspects in atrial fibrillation care Stroke Prevention EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Claudio Tondo

Centro Cardiologico Monzino-IRCCS, Milano (Italy)

5 More presentations in this session

Presentation thumbnail
Association between atrial fibrillation and dementia, with a particular focus on early-onset dementia: a longitudinal population-based study in catalonia, spain
Mr J. Rodriguez Garcia (Hospitalet De Llobregat, ES)
Abstract Slides Video
Presentation thumbnail
The impact of timing and order of disease development on the risk of mortality in atrial fibrillation and heart failure patients
Ms A. Zandijk (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Incidence and predictors of major bleeding among patients receiving apixaban or aspirin for subclinical atrial fibrillation: insights from the ARTESiA sub-analysis
Doctor D. Siegal (Ottawa, CA)
Abstract Slides Video
Presentation thumbnail
Multimorbidity and risk of atrial fibrillation in the Lifelines Cohort
Miss C. Van Deutekom (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Comparison of CHA2DS2-VA and CHA2DS2-VASc scores for predicting residual risk of stroke and adverse outcomes in anticoagulated patients with atrial fibrillation: a report from a European registry
Doctor D. Mei (Modena, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical aspects in atrial fibrillation care
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Discussion - EMBOL-AF
thumbnail
Congress Presentation
Discussion - SWISS-APERO
thumbnail
Congress Presentation
Panel discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources